BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18028489)

  • 21. [Legionella pneumonia in patients treated with infliximab].
    Vinter H; Nielsen HI
    Ugeskr Laeger; 2009 Jan; 171(4):247. PubMed ID: 19174042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute alveolitis following infliximab therapy for psoriasis.
    Bale J; Chee P
    Australas J Dermatol; 2013 Feb; 54(1):61-3. PubMed ID: 22780696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential complications associated with the use of biologic agents for psoriasis.
    Zeichner JA; Lebwohl M
    Dermatol Clin; 2007 Apr; 25(2):207-13, vii. PubMed ID: 17430757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab (Remicade) for acute, severe pustular and erythrodermic psoriasis.
    Lisby S; Gniadecki R
    Acta Derm Venereol; 2004; 84(3):247-8. PubMed ID: 15202853
    [No Abstract]   [Full Text] [Related]  

  • 25. [Multiple lesions of focal cutaneous mucinosis: a side-effect of anti-TNF alpha therapy?].
    Duparc A; Gosset P; Lasek A; Modiano P
    Ann Dermatol Venereol; 2010 Feb; 137(2):140-2. PubMed ID: 20171438
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of bullous pemphigoid during treatment of psoriasis with adalimumab.
    Stausbøl-Grøn B; Deleuran M; Sommer Hansen E; Kragballe K
    Clin Exp Dermatol; 2009 Oct; 34(7):e285-6. PubMed ID: 19438555
    [No Abstract]   [Full Text] [Related]  

  • 27. Severe recalcitrant nail psoriasis responding dramatically to infliximab: report of two patients.
    Hussain W; Coulson I; Owen C
    Clin Exp Dermatol; 2008 Jul; 33(4):520-2. PubMed ID: 18462438
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of linear IgA bullous dermatosis in a patient with psoriasis taking ustekinumab.
    Becker JG; Mundi JP; Newlove T; Mones J; Shupack J
    J Am Acad Dermatol; 2012 Oct; 67(4):e150-1. PubMed ID: 22980274
    [No Abstract]   [Full Text] [Related]  

  • 29. [Splenic tuberculosis during psoriasis treatment with infliximab].
    Fortaleza GT; Brito Mde F; Santos JB; Figueiredo AR; Gomes P
    An Bras Dermatol; 2009; 84(4):420-4. PubMed ID: 19851677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alopecia areata during treatment with biologic agents.
    Tosti A; Pazzaglia M; Starace M; Bellavista S; Vincenzi C; Tonelli G
    Arch Dermatol; 2006 Dec; 142(12):1653-4. PubMed ID: 17179002
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate.
    Warren RB; Brown BC; Carmichael AJ; Griffiths CE
    Clin Exp Dermatol; 2009 Apr; 34(3):415-6. PubMed ID: 19120390
    [No Abstract]   [Full Text] [Related]  

  • 32. Cutaneous pseudolymphoma induced by adalimumab and reproduced by infliximab in a patient with arthropathic psoriasis.
    Imafuku S; Ito K; Nakayama J
    Br J Dermatol; 2012 Mar; 166(3):675-8. PubMed ID: 21910704
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of chronic inflammatory demyelinating polyneuropathy in a patient receiving infliximab for psoriasis.
    Foulkes AC; Wheeler L; Gosal D; Griffiths CE; Warren RB
    Br J Dermatol; 2014 Jan; 170(1):206-9. PubMed ID: 23909440
    [No Abstract]   [Full Text] [Related]  

  • 34. [Our experience with infliximab in reclacitrant cases of psoriasis].
    Pereiro M; González-Vilas D; Sánchez-Aguilar D; Toribio J
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():43-7. PubMed ID: 19080991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous Mycobacterium haemophilum infection in a patient receiving infliximab for psoriasis.
    Aslam A; Green RL; Motta L; Ghrew M; Griffiths CE; Warren RB
    Br J Dermatol; 2013 Feb; 168(2):446-7. PubMed ID: 22816532
    [No Abstract]   [Full Text] [Related]  

  • 36. Efalizumab-induced aseptic meningitis.
    Kluger N; Girard C; Gonzalez V; Guillot B; Bessis D
    Br J Dermatol; 2007 Jan; 156(1):189-91. PubMed ID: 17199599
    [No Abstract]   [Full Text] [Related]  

  • 37. Dermatitis during efalizumab treatment in a patient with psoriasis vulgaris.
    de Groot M; de Rie MA; Bos JD
    Br J Dermatol; 2005 Oct; 153(4):843-4. PubMed ID: 16181475
    [No Abstract]   [Full Text] [Related]  

  • 38. [Infectious risk].
    Calabuig E; Salavert M
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infliximab-induced eczematid-like purpura of Doucas and Kapetenakis.
    Wang LC; Medenica MM; Shea CR; Busbey S
    J Am Acad Dermatol; 2003 Jul; 49(1):157-8. PubMed ID: 12833033
    [No Abstract]   [Full Text] [Related]  

  • 40. [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].
    Puig L
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():30-5. PubMed ID: 19080989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.